| treatment group |
| Results Total effective rate in the treatment group and the control group was 85% and 37.5%,respectively. |
| 结果治疗组20例总有效率85%,对照组16例总有效率37.5%。 |
|
|
| The changes of hemorheology parameters were significiant differences in the treatment group comparing with the control group(P < 0.01). |
| 结果治疗组和对照组神经功能缺损评分差异有统计学意义(P<0.01),2组血液流变学指标比较有统计学意义(P<0.01)。 |
|
|
| Importantly,the death rate and serum ammonia in comprehensive treatment group were significantly decreased than that in control(P<0.05). |
| 综合治疗组死亡率和血氨浓度也显著降低(P<0.05)。 |
|
|
| 75 female recipient SD rats were divided randomly into five groups:lung injury group,MSCs treatment group,MSCs control group,mononuclear cells control group and normal control group. |
| 75只受体大鼠随机分为5组(n=15):肺损伤组、MSCs治疗组、MSCs对照组、单个核细胞对照组和正常对照组。 |
|
|
| Results Apoptotic index(AI)of breast cancer in the treatment group was 8.74%,while that of the control group was 4.65%. |
| 结果乳腺癌细胞凋亡指数(AI)治疗组为7.28%±2.68%,对照组为4.21%±1.87%; |
|
|
| The bcl-2 expression in treatment group was 0.68±0.06,while in control group was 2.24±0.36.Expression of bax in treatment group was 0.72±0.06,while in control group was 0.38±0.04(P<0.05). |
| bcl-2基因的表达,治疗组为0.68±0.06,对照组为2.24±0.36; bax基因的表达,治疗组为0.72±0.06,对照组为0.38±0.04。 |
|
|
| Methods: Guinea pigs were randomly divided into the glutamate injury model group, the normal control group and the bFGF treatment group. |
| 方法:豚鼠随机分成谷氨酸钠损伤组、对照组和bFGF治疗组。 |
|
|
| Methods:Rats were divided into normal control group, Thy1 glomerulonephritis group and valsartan treatment group. |
| 方法:设正常组、Thy1肾炎组及Thy1肾炎+缬沙坦治疗组。 |
|
|
| In valsartan treatment group, glomerular hypercellularity, mesangial matrix expansion and PCNA expression were significantly reduced as compared with those of the untreated rats with Thy1 glomerulonephritis from day 3 to day 7 (P<0.05), and CDK2 expression in glomeruli was lower than that in Thy1 glomerulonephritis group. |
| 缬沙坦治疗组第3~7d肾小球系膜细胞增生、系膜区扩张程度以及肾小球内PCNA表达低于肾炎组(P<0.05),肾小球内CDK2表达也低于肾炎组相应时间点(P<0.05)。 |
|
|
| Results Both methods improvee the neural function, but ESS scores in treatment group were significantly higher than that in control group(P<0.05). |
| 结果治疗后两组神经功能缺损均有改善,但治疗组ESS评分明显高于对照组(P<0.05); |
|
|
| Methods All cases were divided randomly into treatment group(groupⅠ,32cases) and control group(group Ⅱ,30cases) ,and healthy children were also selected as normal control group(group Ⅲ,30cases). |
| 方法随机分低分子肝素钙治疗组(Ⅰ组,32例),普通治疗组(Ⅱ组,30例),并设健康对照(Ⅲ组,30例)。 |
|
|
| Result After 4-week treatment the scores of FMA, MBI and nervous afunction of two kinds of apoplexia patients in the treatment group was better than those in the control group (P<0.05). |
| 结果两种性质中风病人在治疗4周后,FMA、MBI指数及神经功能缺损程度评分,治疗组均优于对照组(P<0.05)。 |
|
|
| The NSE detection result showed that there was a great significant difference between the model group and treatment group (P<0.01). |
| NSE结果显示:模型组和治疗组NSE上升有极显著差异(P<0.01); |
|
|
| Results In the treatment group the total effective rate of symptoms was 95.0 %(P<0.05 comparing between two groups) . |
| 结果治疗组临床证候总有效率为95.0%,两组比较P<0.05。 |
|
|
| The result of the treatment group was better than that of the control group(P<0.01) in symptom relief and imaging changes. |
| 治疗组在改善脂肪肝患者的症状及影像学改变等方面的作用优于对照组,P<0.01。 |
|
|
| Results ① The score of HAMD showed that the total effectual rate and effective rate was 79.41 % and 88.24 % respectively in the treatment group,and 62.50 % and 81.25 % in the control group. |
| 结果①汉密顿抑郁量表(HAMD)评分显示,治疗组总显效率、总有效率分别为79.41%、88.24%; 对照组为62.50%、81.25%。 |
|
|
| The comparison between two groups showed that P>0.05.② According to the relief of RA the total effectual rate and effective rate was 79.41 % and 91.18 % respectively in the treatment group,and 71.88 % and 87.50 % in the control group. |
| 两组比较,P>0.05。 ②按RA改善程度评估临床疗效,治疗组总显效率、总有效率分别为79.41%、91.18%; |
|
|
| Methods Ninety-eight patients with COPD were divided into control group(52 cases) and treatment group(46 cases) at random. |
| 方法98例患者随机分成治疗组(52例)、对照组(46例)。 |
|
|
| The treatment group were received nebulizing inhalation of ambroxol hydrochloride 15mg every time,3 times daily. |
| 治疗组雾化吸入盐酸氨溴索15 mg,3次/d,对照组静脉注射盐酸氨溴索15 mg,3次/d。 |
|
|
| The reaction rate to ambroxol hydrochloride in treatment group was higher than that in the control(94.7% to 71.9%),but the incidence of ventilation associated pneumonia in the treatment group was lower than that in the control group(36.84% to 56.14%). |
| 治疗组、对照组祛痰总有效率分别为94.7%和71.9%,呼吸机相关性肺炎(VAP)感染率分别为36.84%,56.14%。 |
|
|